Login to Your Account



Inverseon, CBio Combine Programs in All-Stock Merger

By Marie Powers
Staff Writer

Thursday, August 30, 2012
Australian drug developer CBio Ltd. acquired privately held Inverseon Inc. in an all-stock deal, creating Invion Ltd., which will operate from offices in San Francisco and Brisbane.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription